MiddleBrook Pharmaceuticals, a developer and marketer of anti-infective drug products, has opened its administrative and sales office in Westlake, Texas.
Subscribe to our email newsletter
The company’s Germantown facility will continue to house certain personnel and functions, including MiddleBrook’s R&D group. The newly leased 14,971sqft Westlake facility is expected to house up to 60 employees as MiddleBrook grows.
The company also announced that Marc Buxbaum has joined MiddleBrook as associate vice president of sales. Prior to joining MiddleBrook, Mr Buxbaum held various positions of increasing responsibility in sales leadership at Bayer, Elan Pharmaceuticals, Biovail Pharmaceuticals and Salix Pharmaceuticals.
Mr Buxbaum has over 16 years experience in sales, sales management and training. His previous roles include sales representative, district manager, director of training and most recently, area sales director.
John Thievon, president and CEO of MiddleBrook, said: “I am extremely pleased that MiddleBrook’s sales and administrative office is now open in Westlake, Texas. Our Westlake office is close to the Dallas Fort Worth International Airport, and Westlake is an ideal location as we build our national field force and prepare for the nationwide trade and professional launch of Moxatag, the first and only FDA-approved once-daily amoxicillin, in the first half of 2009.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.